Nervous system

Increased Anxiety Syndrome as a Factor of Child Behavioral and Health Disorders during Martial Law
Published in the medical newspaper "Health of Ukraine of the 21st Century" № 4 (565)'2024
Use of a metabolic drug in the complex therapy of patients with open-angle glaucoma
Published in a journal «Ophthalmology. Eastern Europe» Vol 10 № 3’2020
Efficiency of methods of postoperative correction of metabolic homeostasis in patients with acute peritonitis
Published in a journal «Pain, Anaesthesia and Intensive Care» № 2 (83)’2018
Elfunate in the treatment of patients with discirculatory encephalopathy
Published in the journal «Neurology and Neurosurgery. Eastern Europe» Vol 7 № 3’2017
Changes in the functional state of the vascular endothelium, the level of C-reactive protein and cognitive functions in patients with atrial fibrillation and acute cerebrovascular accident under the influence of treatment
Published in the journal «Emergency Medicine» № 3 (98)’2019
Modern concepts of differential diagnosis and treatment of polyneuropathies
Published in a journal «International Neurological Journal» Vol 16 № 2’2020
Medotilin in the treatment of post-stroke cognitive impairment
Combined therapy with Medotilin and Elfunat in the prevention and treatment of neuropsychiatric complications after open heart surgery
Regional Center of Cardiosurgery of Odesa Regional Hospital, Odesa, Ukraine
Post-viral fatigue syndrome in children: does it need to be treated?
Published in a journal «Child's Health» Vol 16 № 6’2021
Aspects of the use of metabolic therapy in patients with cognitive impairment in post-COVID syndrome
Published in the medical newspaper «Health of Ukraine 21st century» № 18 (511)’2021

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design